As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million myTomorrows, a Dutch HealthTech company that connects patients with possible pre-approval treatments, today announced the close of a €25 million financing in order to accelerate the global expansion of its AI-driven platform and enhance access to
